Skip navigation
Physician Notices and Updates
Enhanced monitoring of chikungunya live attenuated vaccine AEFIs thumbnail

Enhanced monitoring of chikungunya live attenuated vaccine AEFIs

CHIK-LAV (trade name IXCHIQ) is a single dose chikungunya live attenuated vaccine authorized for use in Canada for the prevention of disease caused by the chikungunya virus. It is not a publicly funded vaccine in Ontario, but it is available through private sale.
Read more

Blog Posts

Enhanced monitoring of chikungunya live attenuated vaccine AEFIs
CHIK-LAV (trade name IXCHIQ) is a single dose chikungunya live attenuated vaccine authorized for use in Canada for the prevention of disease caused by the chikungunya virus. It is not a publicly funded vaccine in Ontario, but it is available through private sale.
Read more
ISPA Enforcement of high school students; IPV vaccine unavailable to order

Halton Region Public Health is currently enforcing the Immunization of School Pupils Act (ISPA) among high school students born in 2008 – 2011. Students with incomplete immunization records may be suspended from school starting April 30, 2026.

Read more
RSV Prevention Program Update for Infants, High-Risk Children and Older Adults

The Ministry of Health has announced that the 2025/26 maternal, infant, and high-risk children RSV prevention program will come to an end on April 17, 2026.

Read more
Spring 2026 COVID-19 Vaccine Program
Starting in April, COVID-19 vaccines can be administered to specific populations at high-risk of infection as indicated in the Health Care Provider fact sheet and the banner of the Ministry of Health's COVID-19 website.
Read more
Extension on Benzanthine Penicillin G (Bicillin® L-A) Shortage And Temporary Use of Lentocilin S 1200.
The national shortage of Benzathine Penicillin G (Bicillin® L-A) 1,200,000 IU/2mL, indicated as the first line treatment for syphilis, continues to persist.
Read more

Blog Posts

Enhanced monitoring of chikungunya live attenuated vaccine AEFIs
CHIK-LAV (trade name IXCHIQ) is a single dose chikungunya live attenuated vaccine authorized for use in Canada for the prevention of disease caused by the chikungunya virus. It is not a publicly funded vaccine in Ontario, but it is available through private sale.
Read more
ISPA Enforcement of high school students; IPV vaccine unavailable to order

Halton Region Public Health is currently enforcing the Immunization of School Pupils Act (ISPA) among high school students born in 2008 – 2011. Students with incomplete immunization records may be suspended from school starting April 30, 2026.

Read more
RSV Prevention Program Update for Infants, High-Risk Children and Older Adults

The Ministry of Health has announced that the 2025/26 maternal, infant, and high-risk children RSV prevention program will come to an end on April 17, 2026.

Read more
Spring 2026 COVID-19 Vaccine Program
Starting in April, COVID-19 vaccines can be administered to specific populations at high-risk of infection as indicated in the Health Care Provider fact sheet and the banner of the Ministry of Health's COVID-19 website.
Read more
Extension on Benzanthine Penicillin G (Bicillin® L-A) Shortage And Temporary Use of Lentocilin S 1200.
The national shortage of Benzathine Penicillin G (Bicillin® L-A) 1,200,000 IU/2mL, indicated as the first line treatment for syphilis, continues to persist.
Read more
Top